FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41059811000001106: Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2259121000001117 Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2259141000001110 Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has excipient Lactose false Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Is a Ripretinib 50mg tablets true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Is a Qinlock true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has specific active ingredient Ripretinib true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has AMP True Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start